Hyperthermic Intraperitoneal Chemotherapy
Excellence in Research
Board Certified in Surgery
Turaga joined the mesothelioma program at the University of Chicago in 2016 after six years at the Medical College of Wisconsin Cancer Center, where he carved a reputation as a leading specialist in the field of asbestos-related disease.
Surgical Oncologist, Associate Professor of Surgery
“He’s the best mesothelioma doctor around,” surgical patient F.X. Dickert told Asbestos.com. “I was one of his last patients in Wisconsin before he went to Chicago. I thought he did a great job taking care of me. I’d recommend him to anyone.”
Turaga was named director of the Surgical GI Cancer Program and the Regional Therapeutics Program in Chicago.
He has expertise in hyperthermic intraperitoneal chemotherapy (HIPEC), which is used in conjunction with cytoreductive surgery for peritoneal mesothelioma.
HIPEC, which is only used in select cancer centers, is designed to deliver high doses of heated chemotherapy directly to the abdominal organs to kill any tumor cells that evaded surgical removal.
Turaga also has expertise in innovative robotic surgery, which is minimally invasive and promotes quicker recovery times for patients.
“I believe that providing for my patients requires state-of-the-art care which is personalized and compassionate,” he said. “And above all, treating my patients like I would my family.”
Turaga has a special interest in treating advanced malignancies, including cancers that have spread beyond their original sites. He works on colon cancer, appendix cancer and malignant bowel obstructions.
He works closely with Dr. Hedy Kindler, director of the mesothelioma program at the University of Chicago. Both are part of the collaborative tumor board that meets regularly at the cancer center to discuss each mesothelioma patient.
“When someone is faced with a [mesothelioma] diagnosis like this, they need not only our best clinical expertise but our best research experience, and that’s what the University of Chicago does so well,” he said. “We have an incredible wealth of experience in this program.”
Turaga completed fellowships at the Moffitt Cancer Center in Tampa and the University of Pittsburgh Medical Center. Both hospitals are known for their work with mesothelioma patients.
He graduated from the All India Institute of Medical Sciences in New Delhi and completed his residency at Creighton University Medical Center.
He has published more than 100 peer-reviewed articles, including one in the Annals of Surgical Oncology that detailed the high percentage of mesothelioma patients who unknowingly bypassed surgical options that could have significantly extended their survival.
“Surgery is a really good option — most patients can benefit,” he said in 2014 while at the Medical College of Wisconsin. “But I think too often, it’s not being offered or recommended.”
Disclaimer: Dr. Kiran Turaga has no professional affiliation with Asbestos.com.
Tim Povtak is an award-winning writer with more than 30 years of reporting national and international news. His specialty is interviewing top mesothelioma specialists and researchers, reporting the latest news at mesothelioma cancer centers and talking with survivors and caregivers.